Hyperfine EBITDA 2021-2025 | HYPR

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Hyperfine ebitda from 2021 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Hyperfine ebitda from 2021 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Related Stocks
Company Name	Market Cap
Intuitive Surgical (ISRG)	$188.5B
Thermo Fisher Scientific (TMO)	$162.6B
Edwards Lifesciences (EW)	$46.2B
Alcon (ALC)	$43.8B
IDEXX Laboratories (IDXX)	$43.5B
DexCom (DXCM)	$33.5B
IQVIA Holdings (IQV)	$28.6B
Mettler-Toledo (MTD)	$25.7B
STERIS (STE)	$22.7B
Waters (WAT)	$21B
SONOVA HOLDING (SONVY)	$17.7B
Hologic (HOLX)	$14.9B
Sysmex ADR (SSMXY)	$10.5B
Penumbra (PEN)	$9.4B
Masimo (MASI)	$9B
Globus Medical (GMED)	$7.8B
Glaukos (GKOS)	$6.1B
Teleflex (TFX)	$5.3B
Integer Holdings (ITGR)	$4.2B
TransMedics (TMDX)	$4.2B
PROCEPT BioRobotics (PRCT)	$3.3B
LivaNova (LIVN)	$2.5B
Veracyte (VCYT)	$2.2B
Nihon Kohden (NHNKY)	$2.1B
Elekta AB (EKTAY)	$2B
Alphatec Holdings (ATEC)	$1.7B
Artivion (AORT)	$1.4B
Pulse Biosciences (PLSE)	$1.2B
Paragon 28 (FNA)	$1.1B
OPKO Health (OPK)	$1.1B